共 338 条
[121]
Sindelar JL(2020)Association between diabetes mellitus and lung cancer: meta-analysis Eur. J. Clin. Invest. 110 1607-1842
[122]
Campus B(2017)Obesity, metabolic factors and risk of different histological types of lung cancer: a Mendelian randomization study PLoS ONE 311 881-2899
[123]
Fafard P(2008)The insulin-like growth factor pathway in lung cancer J. Thorac. Oncol. 7 825-975
[124]
St Pierre J(2014)Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts Br. J. Cancer 374 1166-531
[125]
Hoffman SJ(2014)Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs JAMA 7 296-68
[126]
Bruce N(2016)The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis Oncotarget 18 1503-80
[127]
Woolley KE(2016)Clinical implications of genomic discoveries in lung cancer N. Engl. J. Med. 63 503-1265
[128]
Johnston FH(2017)AACR Project Genie: Powering precision medicine through an international consortium Cancer Discov. 93 395-1325
[129]
Korsiak J(2012)Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers Clin. Cancer Res. 48 962-2406
[130]
Rousseau M-C(2003)Risk for smoking-related cancer among relatives of lung cancer patients Cancer Res. 315 425-409